The DAPA-HF Trial: A Momentous Victory in the War against Heart Failure
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Physiology
Reference13 articles.
1. The war against heart failure: the Lancet lecture;Braunwald;Lancet,2015
2. Empagliflozin prevents worsening of cardiac function in an experimental model of pressure overload-induced heart failure;Byrne;JACC Basic Transl. Sci.,2017
3. Can we DECLARE a victory against cardio-renal disease in diabetes?;Connelly;Cell Metab.,2018
4. Empagliflozin improves diastolic function in a nondiabetic rodent model of heart failure with preserved ejection fraction;Connelly;JACC Basic Transl. Sci.,2019
5. SGLT2 inhibition with empagliflozin increases circulating provascular progenitor cells in people with type 2 diabetes mellitus;Hess;Cell Metab.,2019
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diagnostic and classification criteria of heart failure in the practice of doctors at the prehospital stage;EMERGENCY MEDICINE;2024-05-17
2. Efficacy and Safety of Empagliflozin According to Background Diuretic Use in HFrEF;JACC: Heart Failure;2024-01
3. Managing heart failure in diabetics with dual acting sotagliflozin—A review;Health Sciences Review;2023-12
4. Empagliflozin improves circulating vascular regenerative cell content in people without diabetes with risk factors for adverse cardiac remodeling;American Journal of Physiology-Heart and Circulatory Physiology;2023-11-01
5. Sizing SGLT2 Inhibitors Up: From a Molecular to a Morpho-Functional Point of View;International Journal of Molecular Sciences;2023-09-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3